Endobronchial Ultrasound Biopsy Market To Reach $214.39 Million By 2033

May 2026 | Report Format: Electronic (PDF)

Endobronchial Ultrasound Biopsy Market Growth & Trends

The global endobronchial ultrasound biopsy market size is expected to reach USD 214.39 million by 2033, registering a CAGR of 5.25% from 2026 to 2033, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing incidence of cancer, advancements in Endobronchial Ultrasound (EBUS) technology, a rising elderly population, a higher occurrence of respiratory diseases, and the growing acceptance of minimally invasive procedures. For instance, the World Health Organization (WHO) estimates that there will be more than 35 million new cancer cases in 2050, representing a 77% rise from the estimated 20 million cases recorded in 2022.

The endobronchial ultrasound biopsy market is also driven by advancements in medical technology and the increasing prevalence of respiratory diseases. EBUS devices are primarily used for diagnosing lung cancer, tuberculosis, and other respiratory disorders, offering a minimally invasive alternative to traditional surgical biopsies. Technological innovations such as high-resolution imaging, AI-assisted navigation, and improved probe designs have further enhanced the precision and efficiency of EBUS procedures. In addition, the shift toward personalized medicine and early detection strategies in oncology has enhanced demand for these devices, as they support targeted diagnostic interventions that improve patient outcomes.

Moreover, the market's growth is also fueled by demographic trends such as the growing geriatric population, which is more vulnerable to respiratory conditions such as COPD and asthma. For instance, according to the U.S. Census Bureau, around 57.88% of the country’s population was aged 65 years and above in 2023, accounting for 17.5% of the total population. This geriatric population share is further expected to increase over the forecast period. Furthermore, emerging economies are also witnessing market growth due to their large patient pools affected by air pollution-related respiratory disorders. For instance, countries such as China and India have seen increased adoption of EBUS devices due to high rates of lung cancer linked to poor air quality. Moreover, cost-effectiveness compared to invasive alternatives such as mediastinoscopy has made EBUS attractive for healthcare providers.

key Request a free sample copy or view report summary: Endobronchial Ultrasound Biopsy Market Report

Endobronchial Ultrasound Biopsy Market Report Highlights

The EBUS scopes segment is expected to grow significantly over the forecast period, owing to the demand for minimally invasive lung cancer and mediastinal lymphadenopathy diagnostic procedures
The EBUS-Transbronchial Needle Aspiration (EBUS-TBNA) segment led the market with the largest revenue share in 2025. Clinicians and healthcare providers have shifted toward EBUS-TBNA due to its higher diagnostic yield, reduced patient discomfort, and lower complication rates compared to conventional mediastinoscopy
The hospitals segment accounted for the largest revenue share of 52.0 in 2025. Hospitals prioritize EBUS technology due to its high diagnostic accuracy and reduced patient risk compared to traditional biopsy methods.
The ambulatory surgical centers segment is expected to grow fastest over the forecast period. Ambulatory surgical centers offer a lower-cost alternative to hospitals while maintaining high procedural efficiency, making them an attractive option for patients and payers.
Asia Pacific held the largest revenue share of 43.6% in the endobronchial ultrasound (EBUS) biopsy market in 2025, supported by the growing prevalence of lung cancer, improved healthcare accessibility, and increasing demand for minimally invasive procedures.

Endobronchial Ultrasound Biopsy Market Segmentation

Grand View Research has segmented the global endobronchial ultrasound (EBUS) biopsy market report based on product, procedure, end use, and region:

Product Outlook (Revenue in USD Million, Annual Equipment Sale, Installed Base, 2021 - 2033)

Product Equipment
- EBUS Scopes
  - Convex (CP-EBUS Scope)
  - Radial (RP-EBUS Probe)
- Ultrasound Processors and Imaging Systems
Product Consumables
- EBUS-TBNA Needles
- EBUS-Related Bronchoscopic Procedure Consumables and Accessories
  - Biopsy Forceps
  - Cytology Brushes
  - Cryoprobes
  - Guide Sheaths
  - Accessories (Disposable Suction and Biopsy Valves, Specimen Traps and Collection Accessories, Other Procedure Accessories, etc.)

Procedure Outlook (Number of Procedures in Thousand, 2021 - 2033)

EBUS Scopes
- Convex-probe (Linear / CP-EBUS) Scopes
- By Indication
  - Lung Cancer Staging
  - Sarcoidosis/Others
Radial-probe (RP-EBUS) Scopes

End Use Outlook (Revenue in USD Million, 2021 - 2033)

Hospitals
- Community Hospitals
- Academic/Teaching Hospitals
- Large Multispecialty Hospitals/Networks
Ambulatory Surgical Centers (ASCs)
- Independent ASCs
- Hospital-Affiliated ASCs
Specialty Clinics